We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.72B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Avg Time Held
5.7
years
Top 10 Avg Time Held
5
years
Top 20 Avg Time Held
5.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Splunk Inc
SPLK
|
+$164M |
| 2 |
Fidelity National Information Services
FIS
|
+$140M |
| 3 |
Intel
INTC
|
+$124M |
| 4 |
GSK
GSK
|
+$111M |
| 5 |
Mobileye
MBLY
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$753M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$370M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Charles Schwab
SCHW
|
+$197M |
| 5 |
Morgan Stanley
MS
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.17% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Pulmonx
LUNG
$79.5M
| $46.4M | 0.04% |
5,502,721
+69,970
| +1% | +$665K |
2020 Q4
8 quarters
|
|
177
RTX Corp
RTX
$252B
| $41.9M | 0.04% |
414,932
-93,830
| -18% | -$8.83M |
2013 Q4
36 quarters
|
|
178
Netflix
NFLX
$302B
| $41.2M | 0.04% |
1,397,100
+38,000
| +3% | +$1.07M |
2022 Q2
2 quarters
|
|
179
LPL Financial
LPLA
$25.8B
| $39.7M | 0.04% |
183,600
-79,700
| -30% | -$18.6M |
2020 Q1
11 quarters
|
|
180
Ryanair
RYAAY
$27B
| $39.1M | 0.04% |
1,306,250
| – | – |
2017 Q4
20 quarters
|
|
181
Salesforce
CRM
$203B
| $38.4M | 0.04% |
289,800
| – | – |
2013 Q2
38 quarters
|
|
182
Stratasys
SSYS
$624M
| $36.2M | 0.03% |
3,054,999
-365,700
| -11% | -$4.88M |
2013 Q2
38 quarters
|
|
183
Nektar Therapeutics
NKTR
$1.29B
| $35.4M | 0.03% |
1,043,937
-50,893
| -5% | -$2.46M |
2013 Q2
38 quarters
|
|
184
Array Technologies
ARRY
$550M
| $35.2M | 0.03% |
1,822,600
-560,000
| -24% | -$10.6M |
2022 Q2
2 quarters
|
|
|
MAXR
185
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $34.3M | 0.03% |
663,600
-183,640
| -22% | -$5.04M |
2018 Q2
18 quarters
|
|
186
JetBlue
JBLU
$1.19B
| $34.2M | 0.03% |
5,277,400
-553,100
| -9% | -$4.04M |
2013 Q2
38 quarters
|
|
187
nVent Electric
NVT
$23.6B
| $33.9M | 0.03% |
880,400
-6,600
| -0.7% | -$244K |
2018 Q2
18 quarters
|
|
188
Ulta Beauty
ULTA
$26B
| $32.4M | 0.03% |
69,000
-3,000
| -4% | -$1.29M |
2017 Q4
20 quarters
|
|
189
Cerus
CERS
$455M
| $32.3M | 0.03% |
8,849,600
-418,900
| -5% | -$1.58M |
2015 Q1
31 quarters
|
|
190
Okta
OKTA
$36.5B
| $32.1M | 0.03% |
470,466
+375,116
| +393% | +$21.4M |
2020 Q1
11 quarters
|
|
191
DELISTED
Altair Engineering Inc
ALTR
| $31.3M | 0.03% |
688,050
-65,350
| -9% | -$3.06M |
2017 Q4
20 quarters
|
|
192
Allogene Therapeutics
ALLO
$463M
| $31.1M | 0.03% |
4,943,916
+51,050
| +1% | +$473K |
2020 Q4
8 quarters
|
|
193
Old Dominion Freight Line
ODFL
$39.2B
| $30.9M | 0.03% |
218,100
-145,600
| -40% | -$20.7M |
2017 Q2
22 quarters
|
|
194
HubSpot
HUBS
$11.9B
| $30.1M | 0.03% |
104,000
-31,825
| -23% | -$9.02M |
2016 Q1
27 quarters
|
|
195
Uber
UBER
$146B
| $30.1M | 0.03% |
1,215,650
-12,450
| -1% | -$341K |
2020 Q2
10 quarters
|
|
196
Norwegian Cruise Line
NCLH
$7.07B
| $30M | 0.03% |
2,453,370
-9,700
| -0.4% | -$146K |
2014 Q1
35 quarters
|
|
197
Lowe's Companies
LOW
$110B
| $29.9M | 0.03% |
150,000
-80,000
| -35% | -$16M |
2021 Q1
7 quarters
|
|
198
Wave Life Sciences
WVE
$629M
| $29.3M | 0.03% |
4,189,608
-220,300
| -5% | -$1.02M |
2019 Q3
13 quarters
|
|
199
Danaher
DHR
$163B
| $29.3M | 0.03% |
124,347
| – | – |
2021 Q2
6 quarters
|
|
200
Sphere Entertainment
SPHR
$3.91B
| $28.9M | 0.03% |
642,751
-2,000
| -0.3% | -$90.6K |
2020 Q2
10 quarters
|
|
Similar funds
Primecap Management's Q4 2022 Portfolio in Review
As of Q4 2022, Primecap Management held 343 positions worth $109B, up 5.7% from $103B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $3.72B in Q4 2022, closing 9 positions and reducing 229 holdings. Its most notable exit was Abiomed Inc, an estimated $370M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Mobileye worth $72.3M.
- Primecap Management's largest Q4 2022 buy was Mobileye: 2,061,470 shares worth $72.3M.
- Primecap Management added most to Splunk Inc in Q4 2022, an estimated $164M increase.
- Primecap Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $753M.
- Primecap Management fully exited Abiomed Inc in Q4 2022, selling an estimated $370M.
- Primecap Management's ten largest holdings make up 33% of its $109B portfolio in Q4 2022.
- Primecap Management opened 8 new positions and closed 9 in Q4 2022.
- Primecap Management's portfolio value rose 5.7% quarter-over-quarter to $109B.
Based on Primecap Management's 13F filing for Q4 2022, filed 13 Feb 2023.